Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11469 posts found.

Venatorx and Menarini enter commercial agreement for cefepime-taniborbactam

January 11, 2024 Sales and Marketing Infections and infestations, Menarini Group, Venatorx Pharmaceuticals, cefepime-taniborbactam, collaboration

Venatorx Pharmaceuticals and Menarini Group have announced that they have entered into a commercial agreement valid in 96 countries in …
News

Consilient Health to launch Cytisine smoking cessation treatment in UK

January 8, 2024 Sales and Marketing Cytisine, Smoking Cessation, consilient health, smoking cessation

Consilient Health has announced that it plans to launch Cytisine 1.5mg tablets in the UK on 22 January 2024. The …
News

C4X receives $11m milestone payment from AstraZeneca

January 3, 2024 Sales and Marketing AstraZeneca, C4X, C4X Discovery, Chronic Diseases

C4X Discovery Holdings has announced that it has received a milestone payment of $11m from AstraZeneca which has been triggered …
News

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023 Sales and Marketing AbbVie, Oncology, acquisition

AbbVie and ImmunoGen have announced that AbbVie will acquire ImmunoGen and its lead cancer therapy Elahere (mirvetuximab soratansine-gynx), a first …
News

Sun Pharma and Pharmazz enter license agreement for Tyvalzi in India

September 14, 2023 Sales and Marketing License Agreement, Neurology, Pharmazz, Sun Pharma, Tyvalzi, sovateltide

Sun Pharma has announced that one of its wholly owned subsidiaries has entered into a license agreement with Pharmazz in …
News
headache

AbbVie’s Aquipta receives MHRA marketing authorisation

September 5, 2023 Sales and Marketing AbbVie, Aquipta, MHRA, Neurology, atogepant, migraines

AbbVie has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a marketing authorisation for Aquipta (atogepant), …
News

Takeda and ImmunoGen collaborate for development and commercialisation of Elahere in Japan

August 29, 2023 Sales and Marketing Elahere, Immunogen, Oncology, Takeda

ImmunoGen has announced that it has entered into an exclusive collaboration with Takeda Pharmaceutical Company for the development and commercialisation …
News
medications-money-cure-tablets

Amarin gains positive opinion from Spanish Drug Pricing Committee for national reimbursement of Vazkepa in Spain

July 26, 2023 Sales and Marketing Amarin, Cardiology, Spanish Drug Pricing Committee, Vazkepa, cardiovascular

Amarin has announced that the Spanish Drug Pricing Committee has recommended the national reimbursement of Vazkepa (icosapent ethyl) in Spain …
News

BioIVT acquires PrecisionMed for neurology and oncology research

July 21, 2023 Sales and Marketing Neurology, Oncology, neurology, oncology

BioIVT has announced that it has acquired PrecisionMed, a leading supplier of high-quality human biological material for genetics, drug discovery …
News

Eli Lilly to acquire Versanis Bio for $1.9bn

July 17, 2023 Sales and Marketing Cardiology, Eli Lilly, Versanis Bio, acquisition, cardiometabolic diseases

Eli Lilly and Versanis Bio have announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company …
News

Nanobiotix announces license agreement with Janssen for development and commercialisation of new cancer treatment

July 10, 2023 Sales and Marketing Cancer, Janssen, License Agreement, Oncology, nanobiotix

Nanobiotix has announced a global licensing, co-development and commercialisation agreement with Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies …
News

XOMA acquires royalty and milestone rights for NPC and pancreatic cancer assets

June 23, 2023 Sales and Marketing Cancer, Oncology, Xoma, acquisition, oncology

US-based biotechnology royalty aggregator XOMA has announced that it has gained the royalty and milestone rights for two assets from …
News

Report finds NHS may miss out on new drugs due to rising costs

June 5, 2023 Sales and Marketing LSE, LSHTM, NHS, Pharmacy, University of York, drug prices

Figures from a team at the University of York, the London School of Economics and Political Science (LSE) and the …
News

Pharmanovia and Stealth BioTherapeutics enter new licensing agreement for novel Barth syndrome treatment

May 31, 2023 Sales and Marketing Barth syndrome, Cardiology, Pharmanovia, Stealth BioTherapeutics, licensing agreement

Pharmanovia and Stealth BioTherapeutics have announced that they have entered into a new licensing agreement for the marketing and further …
News

ElevateBio announced $401m in Series D financing for cell and gene therapies

May 25, 2023 Sales and Marketing ElevateBio, Financing, cell and gene therapies

US-based cell and gene therapy (CGT) company ElevateBio has announced that, at the end of its Series D financing led …
News

Latest content

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024

Intra-Cellular Therapies shares phase 3 results for major depressive disorder therapy

April 17, 2024

Novartis shares new data about Fabhalta for IgAN treatment

April 16, 2024